Change in Albuminuria Is Predictive of Cardiovascular Outcome in Normotensive Patients With Type 2 Diabetes and Microalbuminuria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Change in Albuminuria Is Predictive of Cardiovascular Outcome in Normotensive Patients With Type 2 Diabetes and Microalbuminuria

Published:2007-12-01 Issue:12 Volume:30 Page:3119-3121
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Zandbergen Adrienne A.M.¹,Vogt Liffert²,de Zeeuw Dick²,Lamberts Steven W.J.¹,Ouwendijk Rob J.T.H.³,Baggen Marinus G.A.³,Bootsma Aart H.¹

Affiliation:

1. Department of Internal Medicine, Erasmus University Medical Centre, Erasmus University Rotterdam, Rotterdam, the Netherlands

2. Department of Internal Medicine and Clinical Pharmacology, University Medical Centre Groningen, Groningen, the Netherlands

3. Department of Internal Medicine, Ikazia Hospital Rotterdam, Rotterdam, the Netherlands

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/30/12/3119/595026/zdc01207003119.pdf

Reference15 articles.

1. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yususf S; HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426, 2001

2. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agustino RB, Vasan RS: Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112:969–975, 2005

3. Yuyun MF, Adler AI, Wareham NJ: What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? Curr Opin Nephron Hypertens 14:271–276, 2005

4. Ruilope LM, Segura J: Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence. Clin Ther 25:3044–3064, 2003

5. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869, 2001

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus Statements from the Diabetologists & Endocrinologists Alliance for the Management of People with Hypertension and Type 2 Diabetes Mellitus;Journal of Clinical Medicine;2023-05-11

2. Change in Proteinuria and Renal Function in Patients with Type 2 Diabetes Receiving Standard Treatment;Juntendo Medical Journal;2021

3. Comprehensive risk management of diabetic kidney disease in patients with type 2 diabetes mellitus;Diabetology International;2018-02-27

4. Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study;Diabetes, Obesity and Metabolism;2018-02-20

5. An eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapy;International Journal of Ophthalmology;2016-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3